1. Home
  2. NWGL vs ENLV Comparison

NWGL vs ENLV Comparison

Compare NWGL & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nature Wood Group Limited

NWGL

Nature Wood Group Limited

N/A

Current Price

$1.42

Market Cap

22.8M

Sector

N/A

ML Signal

N/A

Logo Enlivex Therapeutics Ltd.

ENLV

Enlivex Therapeutics Ltd.

HOLD

Current Price

$0.96

Market Cap

26.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NWGL
ENLV
Founded
2008
2005
Country
Macau
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.8M
26.6M
IPO Year
2023
1995

Fundamental Metrics

Financial Performance
Metric
NWGL
ENLV
Price
$1.42
$0.96
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$7.00
AVG Volume (30 Days)
100.2K
11.0M
Earning Date
04-24-2026
11-28-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$21,539,347.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.91
$0.83
52 Week High
$6.61
$2.10

Technical Indicators

Market Signals
Indicator
NWGL
ENLV
Relative Strength Index (RSI) 55.35 46.57
Support Level $1.00 $0.88
Resistance Level $1.23 $1.06
Average True Range (ATR) 0.12 0.12
MACD 0.01 -0.00
Stochastic Oscillator 72.40 14.12

Price Performance

Historical Comparison
NWGL
ENLV

About NWGL Nature Wood Group Limited

Nature Wood Group Ltd is a vertically-integrated forestry company that focuses on FSC business operations. It produces various products, including logs, decking, flooring, sawn timber, recycled charcoal, synthesized charcoal, machine-made charcoal, and essential oils. The Group owns natural forest concessions and cutting rights for exploiting timbers on parcels of land in Peru. The Group is organized into two operating divisions; Direct Purchase and Original Design Manufacturer (ODM) Services, and Manufacturing segments. The Direct Purchase and ODM Segment that derives the majority of revenue engages in the business of sourcing live wood and owning designed designs on wood products for sales to end customers. Geographically, the company generates a majority of its revenue from China.

About ENLV Enlivex Therapeutics Ltd.

Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.

Share on Social Networks: